who has not responded to 7 mc Of P32 and I suggest that the long period without any treatment which might depress his bone-marrow has allowed a great increase in red-cell-forming tissue and a consequent need for a very high dose. Lastly, Fig. 2 who have had more than one therapeutic dose of P32. In all cases where the follow-up is long enough the remissions have become longer. I think this has three possible explanations: the disease in these patients may be dying out, repeated effective doses of P32 may be curing the patients, or thirdly the indications of giving P32 may have changed. I do not think the last is the correct explanation and I would suggest that the disease in these patients is slowly being cured.
Some Experiences with Radioactive Phosphorus in the Treatment of Mycosis Fungoides
By F. E. NEAL, M.B., .Ch.B., D.M.R.T.
Senior Registrar, Sheffield National Centre for Radiotherapy THE purpose of this paper is not to suggest that radioactive phosphorus should be used as the treatment of choice in mycosis fungoides, but merely to describe some of the clinical and physical observations we were able to make on a small number of cases and to show that this method of treatment may be a useful therapeutic agent in the disseminated stages of this disease.
The localized tumours which occur can be satisfactorily treated or controlled for long periods by X-ray therapy. Invariably, however, a stage is reached when the condition fails to respond to therapy, visceral lesions develop, the patient's general condition deteriorates and progresses to a marked cachexia before death supervenes. The two states in which we were particularly interested, were the so-called premycosic erythrodermia and those cases which present widely disseminated but frank superficial lesions of mycosis fungoides. The generalized nature of the eruptions in these two phases contra-indicates the use of orthodox X-ray treatment but it seems probable that the condition would respond to a more generalized form of therapy. In this connexion various chemotherapeutic agents have been used, e.g. antimony derivatives, cortisone and nitrogen mustards, with varying degrees of success. Since it is a radiosensitive condition, however, it would seem that good effect could be achieved with some form of internal radiation therapy.
For this purpose, radioactive phosphorus seemed to be the isotope of choice. It is known that increased uptake of P32 occurs in tissues exhibiting high metabolic activity and the ,B rays have a maximum range in tissue of 7-8 mm. Therefore, effective irradiation dosage could be delivered to the superficial lesions with the minimum irradiation of surrounding areas, provided that effective uptake was obtained.
The increased uptake of P32 occurring in the skin lesions in two cases of mycosis fungoides was demonstrated by Marinelli and Goldschmidt (1942) and various physical measurements on the lesions were described. It seemed that effective irradiation was obtained as the lesions were said to regress-although the clinical description was not complete. Low-Beer (1942) described a similar investigation on 5 cases of localized mycosis fungoides. Two failed to respond, but excellent effect was obtained in a third case in which a large tumour mass in the breast (treated by a combination of internal and external radiation) regressed and remained healed for several years. Laarsen (1952) described 2 cases of disseminated mycosis treated in this way in more clinical detail and obtained good palliation in both cases.
It was with the hope of repeating these encouraging results that we embarked upon this investigation.
SELECTION OF CASES The selection of cases presented very little difficulty. The condition is, fortunately, not common and we were willing to take on all-comers in the hope of achieving palliation. During the past year, 5 such cases have been treated by this method, 2 cases presenting premycosic erythrodermia and the others having widespread mycotic lesions.
In the first group of cases (the premycosic stage) both patients gave a history of recent onset of symptoms, the condition persisting in one case, in spite of treatment with cortisone.
The second group of cases were all of long standing and had failed to respond to previous treatments, including cortisone and X-ray therapy. In 2 cases the lesions involved the whole of the trunk and limbs, in the third case they were confined mainly to the face and scalp. The lesions were of the superficial weeping eczematous, or dry scaly type, and the patients were in a state of continual discomfort due to the exudation from the lesions.
Pruritus was the most prominent symptom in all cases. When first examined, there was no evidence of visceral extension in any case and pre-treatment blood counts and marrow examination were all within normal limits. Histological confirmation was obtained in all cases.
TREATMENT TECHNIQUE
The treatment was carried out over a period varying from six weeks to six months. Radioactive phosphorus was given in the form of sodium hypophosphate and given in each case by intravenous injection. Since all the patients were hospitalized, this seemed to be the most convenient method of administration and eliminated the necessity of rigorous nursing precautions. The amounts of P32 given varied from 8 mc in six weeks, to 39 mc in twenty-three weeks. The smaller amounts were used in the treatment of the cases of premycosic erythrodermia.
No attempt was made to precalculate the dosage given. The amount given in each case was controlled by routine checks on the blood picture, the general condition of the patient and the progress of the local lesions.
No physical measurements were carried out on the 2 cases in the first group as no normal skin was available for comparison. 2 of the other cases were investigated in detail and the fifth case (which was treated rather more cautiously) was controlled on the results so obtained.
PHYSICAL INVESTIGATIONS
Injections of P32 were given at approximately monthly intervals and physical measurements were made for approximately fourteen days thereafter. The poor general condition of the patients necessarily limited the number of investigations performed, as we wished to subject them to the minimum of biopsies and venepunctures.
A specific lesion was chosen, biopsies being taken from this and a corresponding area of normal skin on 2-3 occasions after each injection. The tissue obtained was weighed, dissolved in concentrated hydrochloric acid and measurements were made in an M. 6 liquid counter compared against a standard taken from the original injection of P32.
A similar technique was used to obtain values for the blood and bone-marrow (Table I) . At a later stage in the treatment, measurements were made of superficial lesions and corresponding areas of normal skin, using a modified G.M.4 end window counter, having a brass housing with a collimating cylinder 1-5 cm. diameter. This allowed exact repositioning of the counter on different occasions. By this means isodose conitours were obtained. The counter was calibrated against a solution containing a known amount of P32. Some difficulty was experienced in obtaining exactly reproducible results, due presumably to the varying amounts of incrustations over the lesion on different occasions (see Fig. 1 ). In both cases there was found to be an increased uptake in the lesion compared to the uptake in normal skin. The relative amount being three to seven times greater in the lesions. The uptake in the blood and bone-marrow was comparable to the uptake in normal skin. It should be emphasized that the doses shown are only an approximation, and apply only to the surface layers of tissue, since the half-value layer of the P32 beta rays in tissue is only of the order of 1 mm. The half-life of the P32 in the lesions was considerably shorter than that in normal skin and blood, presumably due to the increased metabolic activity in the lesion. To avoid errors due to increased vascularity in the neighbourhood of the lesions, vasodilation was produced over a small area of normal skin. No increase in counting rate (greater than 2-3 %) was observed in this area as compared with the normal skin.
MYCOSIS FUNGOIDES
The dose to the blood and bone-marrow was in all cases relatively low, but in one case, marked depression of the platelet count was noticed (see Fig. 2 ). In all other cases the blood picture remained within normal limits throughout treatment. CLiNcAL RESULTS In all cases there was a subjective improvement and a temporary or permanent relief of pruritus. Of the 2 cases presenting with erythrodermia (see Table II ) 1 improved rapidly, and three months after commencing treatment was symptom free and the skin had returned to normal. It has remained so, for the past year. The second case did not respond well. There was a little relief of pruritus but the skin condition did not change and treatment had to be abandoned because of intercurrent illness.
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A I In the second group of cases, one patient did not respond well (see Table IT ). A little temporary relief of pruritus was obtained but the skin lesions did not change. A gradual improvement was noticed in the case presenting with lesions on the face and scalp and this improvement has been maintained although further lesions have developed on the trunk and lower limbs (see Fig. 3 ). The lesions in Case III began to fade three weeks after commencing treatment and continued to improve for four months (see Figs. 4, 5 and 6) 
DISCUSSION
The natural history of the disease-characterized by spontaneous regression and recurrence of lesions-makes it difficult to assess adequately any form of therapy especially on a small number of cases. However, increased take-up of radioactive phosphorus was demonstrated in the lesions and approximate doses calculated.
The improvement of the lesions in 3 of the cases under consideration cannot be ignored completely. The amount of radioactive phosphorus given was not as large as was originally intended, but must have been sufficient to give adequate irradiation to the lesions for regression to have occurred. Even with these relatively small amounts of p32, marked depression of the platelet count was produced in one case. Laarsen (1952) obtained satisfactory palliation in one case with approximate lesion dose of 500 r e.p. but suggested that it would be improbable that smaller doses than this would have any useful effect. In this series the amount of phosphorus given was smaller and given over a larger period of time, yet regression of lesions occurred. Since serious heematopoietic disorders can arise with this form of therapy, it would seem that the lower dosage rate is perhaps a preferable form of therapy. The temporary or permanent relief of pruritus obtained is an important fact. This is a common symptom in all forms of malignant skin disease and radioactive phosphorus may prove a useful method of relieving this distressing condition.
It should be emphasized that the aim of this investigation was to produce palliation in the first instance. For localized lesions X-ray therapy remains the treatment of choice, but for the more widespread forms of the disease p32 would seem to have a useful effect in some cases. 
SUMMARY
The treatment of 5 cases of disseminated mycosis fungoides by multiple injections of radioactive phosphorus over a long period is described. The physical measurements and data obtained are recorded and the palliative effect likely to be obtained from this form of therapy is briefly discussed.
